What Has Been the Progress and Growth of the Live Cell Imaging Market in Recent Years?
The live cell imaging market has seen considerable growth due to a variety of factors.
• In recent years, the market size for live cell imaging has expanded swiftly. The projections show an increase from $4.99 billion in 2024 to $5.72 billion in 2025, representing a compound annual growth rate (CAGR) of 14.7%.
This impressive growth in the historical period is largely due to factors such as drug discovery and development, cancer research and work in the fields of biotechnology, biopharmaceuticals, clinical applications, as well as cellular and molecular biology.
What Can Be Expected from the Live Cell Imaging Market in the Coming Years?
The live cell imaging market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations are high for a speedy expansion of the live cell imaging market in the coming years. The projected growth rate estimates a market worth of $9.94 billion by 2029, with a compound annual growth rate (CAGR) of 14.8%.
The sizeable growth anticipated during the forecasted period is due to various factors such as infectious disease research, the embrace of personalized medicine, research in environmental and ecological areas, advancement in immunotherapy. The period is also set to witness some significant trends, including 3D and 4D imaging, super-resolution microscopy, high-content screening, live-cell tracking software, and microfluidic devices.
What Main Forces Are Fueling Expansion In The Live Cell Imaging Market?
The escalating prevalence of cancer is projected to steer the expansion of the live cell imaging market in the upcoming period. Identified as the second highest cause of fatalities across the globe, cancer is responsible for one in every six deaths annually. To illustrate, data from the Australian Institute of Health and Welfare—a government institution in Australia that concentrates on distributing comprehensive health and welfare information—in July 2024 revealed that diagnosed cancer cases in Australia escalated from 156,781 in 2021 to 160,570 in 2022. This implies an increase of 3,789 cases within a year. Live cell imaging technology is integral to the progress and affirmation of cancer immunotherapy by providing visualization, characterization, and assessment of the biological function of living cells. Hence, the surging occurrence of cancer propels the growth of the live cell imaging market.
What Are The Primary Segments In The Global Live Cell Imaging Market?
The live cell imaging market covered in this report is segmented –
1) By Product: Equipment, Consumable, Software
2) By Technology: Time-Lapse Microscopy, Fluorescence Recovery After Photobleaching (FRAP), Fluorescence Resonance Energy Transfer (FRET), High Content Screening (HCS), Other Technologies
3) By Application: Cell Biology, Developmental Biology, Stem Cell and Drug Discovery, Other Applications
4) By End-User: Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations (CROs)
Subsegments:
1) By Equipment: Microscopes, Imaging Systems, Light Sheet Microscopes, Cameras And Detectors
2) By Consumable: Cell Culture Plates And Dishes, Reagents And Stains, Media And Supplements, Imaging Sensors
3) By Software: Image Analysis Software, Data Management Software, Visualization Software, Image Processing Tools
Pre-Book The Live Cell Imaging Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Key Trends Are Driving Changes In The Live Cell Imaging Market?
The projection for growth in the live cell imaging market seems constrained by an inadequate supply of skilled professionals. To decipher and examine cellular functions, a substantial level of expertise in live cell imaging technology is required. Data from Healthcare-in-Europe.com, which provides updates on advances and trends in medical technology and research, indicates a severe lack of laboratory skills in the UK and Europe over the coming decade, with medical laboratories bearing the brunt. Furthermore, research conducted by the Gatsby Foundation suggests that there is a need for an additional 700,000 technicians in the UK by 2030 to bolster the economy. Hence, the unavailability of sufficiently trained professionals may impede market growth in the future.
Who Are the Key Players in the Live Cell Imaging Market?
Major companies operating in the live cell imaging market include:
• Leica Microsystems GmbH
• Olympus Corporation
• Sigma-Aldrich Corporation
• PerkinElmer Inc.
• GE Healthcare Technologies Inc.
• Carl Zeiss Meditec AG
• Becton Dickinson and Company
• Molecular Devices LLC
• Bruker Corporation
• Sartorius AG
• Oxford Instruments plc
• BioTek Instruments Inc.
• Etaluma Inc.
• CytoSMART Technologies B.V.
• Blue-Ray Biotech Corp.
• CYTENA GmbH
• Nanolive SA
• Abberior GmbH
• Phase Holographic Imaging AB
• Cytoskeleton Inc.
• Corning Incorporated
• KEYENCE Corporation
• Aligned Genetics Inc.
• Axion BioSystems Inc.
• Bio-Rad Laboratories Inc.
• NanoEnTek Inc.
• Danaher Corporation
• Agilent Technologies Inc.
• Leinco Technologies
• Phasefocus Ltd.
What Is The Most Dominant Region In The Live Cell Imaging Market?
North America was the largest region in the live cell imaging market in 2024. The regions covered in the live cell imaging market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
